Decoy Therapeutics DCOY
NASDAQ DCOY
$2.13 -0.18 (-7.79%)
At close: Sep 29, 2026 · 4:00 PM EDT

Decoy Therapeutics (DCOY) EV to CFO (2018 - 2019)

Updated

Decoy Therapeutics' (DCOY) EV to CFO stood at 338.26 in Q2 2019, down 8.9% from the prior quarter.

Analysis

Decoy Therapeutics (DCOY) EV to CFO (2018 - 2019) Analysis & Trends

On a TTM basis, Decoy Therapeutics' EV to CFO came in at 337.69 as of Jun 30, 2019; for FY2018, it came in at 891.32.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Decoy Therapeutics 1.23 Mn 1.23 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 338.26
Mar 31, 2019 371.29
Dec 31, 2018 891.32
API Access

Decoy Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=DCOY&period=max&api_key=YOUR_API_KEY